Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 13, 2007. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by six individuals on April 12, 2007, at a price of GBP 14.12 per share. These transactions occurred through the Company's ShareReward Plan, specifically under the Dividend Reinvestment element. The individuals involved are:
- Mr J S Heslop: Acquired 12 shares
- Mr R Bondy: Acquired 12 shares
- Mr D Learmouth: Acquired 12 shares
- Dr D Pulman: Acquired 7 shares
- Mr C Viehbacher: Acquired 3 shares
- Mr A P Witty: Acquired 12 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share purchases mentioned above.
Investor Verification Points
- Verify the share price of GBP 14.12 against market data for April 12, 2007.
- Confirm the total number of shares acquired (58 shares) by the listed executives.
- Review the terms of the ShareReward Plan entered into on October 5, 2001, to understand the dividend reinvestment mechanism.